Clinical Trial Update: Bisphosphonate Therapy in MONA Spectrum Disorder

View source ↗

Summary

Completed clinical trial evaluating bisphosphonate therapy for MONA Spectrum Disorder to improve bone density and reduce fracture risk.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mona Spectrum Disorder

Drugs mentioned

• Bisphosphonates (bisphosphonate)

Snippet

Sponsor: Medical University Innsbruck | Conditions: Bone Density, Pain | Status: COMPLETED